Effect of Non-invasive Neuromodulation on the Quality of Intestinal Cleansing (NCT07290816) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effect of Non-invasive Neuromodulation on the Quality of Intestinal Cleansing
China270 participantsStarted 2025-12-31
Plain-language summary
To clarify whether non-invasive neuromodulation for assisted bowel preparation can improve the quality of bowel preparation, to explore the possible mechanisms by which TEA improves the quality of bowel preparation, and to assess its safety, as well as subjects' tolerance, compliance and satisfaction.
Who can participate
Age range18 Years – 78 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18 to 78 years of age, male or female;
* Intended to undergo diagnostic, screening, or surveillance colonoscopy;
* Signed written informed consent.
Exclusion Criteria:
* Severe cardiac, cerebral, pulmonary, or renal complications or a history of acute cardiac infarction within six months;
* High risk factors for bowel preparation such as history of colon surgery, BMI ≥ 28, inflammatory bowel disease, constipation (less than 3 bowel movements in the last week, and with straining to defecate, with hard stools and small amount of stools) or bowel obstruction;
* High suspicion of colorectal cancer by auxiliary examination or early warning signs and symptoms of colorectal cancer: blood in stool, black stool, unexplained anemia, significant weight loss, abdominal mass and positive rectal fingerprinting;
* The presence of surgical incisions or scars in the area where the electrostimulation treatment tablets are pasted, or near the ST36 acupoints on both legs;
* Are participating in other clinical observation trials or have participated in other clinical trials within 30 days.